Alkermes
ALKS
$24.38
Share price
-0.22%
Change (1 day)
-20.08%
Change (1 year)
Categories
Alkermes (ALKS) - Total assets
Total assets on the balance sheet as of December 2023 : $2.13 B
According to Alkermes's latest financial reports the company's total assets are $2.13 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Alkermes - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $2.13 B | 8.77% |
| 2022-12-31 | $1.96 B | -2.99% |
| 2021-12-31 | $2.02 B | 3.83% |
| 2020-12-31 | $1.94 B | 7.99% |
| 2019-12-31 | $1.80 B | -1.07% |
| 2018-12-31 | $1.82 B | 1.55% |
| 2017-12-31 | $1.79 B | 4.1% |
| 2016-12-31 | $1.72 B | -6.97% |
| 2015-12-31 | $1.85 B | -3.3% |
| 2014-12-31 | $1.91 B | |
| 2013-03-31 | $1.47 B | 2.44% |
| 2012-03-31 | $1.43 B | 217.21% |
| 2011-03-31 | $0.45 B | -12.25% |
| 2010-03-31 | $0.51 B | -8.98% |
| 2009-03-31 | $0.56 B | -13.69% |
| 2008-03-31 | $0.65 B | 15.42% |
| 2007-03-31 | $0.56 B | 19.17% |
| 2006-03-31 | $0.47 B | 40.81% |
| 2005-03-31 | $0.33 B | 25.5% |
| 2004-03-31 | $0.27 B | 5.6% |
| 2003-03-31 | $0.25 B | -27.02% |
| 2002-03-31 | $0.35 B | -10.46% |
| 2001-03-31 | $0.39 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 7,743.67% | 🇺🇸 USA |
 Novartis NVS | $99.94 B | 4,578.59% | 🇨🇭 Switzerland |
 Pfizer PFE | $226.50 B | 10,502.89% | 🇺🇸 USA |
 Sanofi SNY | $139.81 B | 6,445.02% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $95.15 B | 4,354.55% | 🇺🇸 USA |
 AstraZeneca AZN | $101.11 B | 4,633.55% | 🇬🇧 UK |
 Zogenix ZGNX | N/A | N/A | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.36 B | -82.85% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $43.47 B | 1,935.32% | 🇮🇱 Israel |